Stephen L. Silvestro - 19 Dec 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Dec 2025, 10:10:09 UTC
Prior SEC filing
07 Oct 2025
Next SEC filing
23 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marion Odence-Ford, by Power of Attorney

Key filing fact

Stephen L. Silvestro filed Form 4 for OptimizeRx Corp (OPRX) on 22 Dec 2025.

Key facts

  • This page summarizes Stephen L. Silvestro's Form 4 filing for OptimizeRx Corp (OPRX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 22 Dec 2025, 10:10.

Change

  • Previous filing in this sequence was filed on 07 Oct 2025.
  • Current net transaction value: -$21,535.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001773461 Primary reporting owner

Silvestro Stephen L

Relationship
Chief Executive Officer
Address
C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Signature date
22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPRX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+6,546
Change %
+3.5%
Price
$0.000000
Shares after
195,462
Date
19 Dec 2025
Ownership
Direct
Footnotes
F1
OPRX transaction

Common Stock

Tax liability

Transaction value
$21,535
Shares
-1,594
Change %
-0.82%
Price
$13.51
Shares after
193,868
Date
19 Dec 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPRX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-6,546
Change %
-50%
Price
$0.000000
Shares after
6,547
Date
19 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,546
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

Footnote F3

The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

SEC remarks

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .